Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397456 · ClinicalTrials.gov registry record · NA
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
A NA study of Hypertension and Chronic Kidney Disease, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06397456: Recruiting NA study of Hypertension and Chronic Kidney Disease, sponsored by University of Chicago.
NCT06397456 is a NA study of Hypertension and Chronic Kidney Disease that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 180 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397456, a NA study of Hypertension and Chronic Kidney Disease, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-management support. Participants will be randomized to the iPREP-RRT intervention versus enhanced usual care.
Primary Outcome
The Kidney Disease Knowledge Questionnaire (KIKS) is a validated instrument that assesses CKD knowledge. Scores range from 0 (no knowledge)-28 (full knowledge). Change =Post intervention-Baseline scores, and Follow-up (Week 4, Week 12, Week 16)-Baseline
Conditions Studied
Interventions
- BEHAVIORAL In-Person Patient Education
- BEHAVIORAL Commitment to Change
- BEHAVIORAL Blood pressure monitoring
- BEHAVIORAL Written Patient Education
- BEHAVIORAL Text-based reinforcement for CKD self-management
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06397456 shows while recruiting
NCT06397456 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 5 interventions - of which In-Person Patient Education is the first listed.
NCT06397456 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06397456 about?
NCT06397456 is a clinical study titled "Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy". Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention that identifies hospitalized African Americans with advanced chronic kidney disease (CKD) and provides them with hospital- and community-based education, navigation and self-mana...
What is the current status of trial NCT06397456?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-09-04. Estimated completion is 2026-06-30.
What conditions does trial NCT06397456 study?
This clinical trial studies the following conditions: Hypertension, Chronic Kidney Disease.
What interventions are being tested in trial NCT06397456?
The interventions under investigation include: In-Person Patient Education (BEHAVIORAL), Commitment to Change (BEHAVIORAL), Blood pressure monitoring (BEHAVIORAL), Written Patient Education (BEHAVIORAL), Text-based reinforcement for CKD self-management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06397456?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397456 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06397456's enrollment target sits among peer trials
180 230th of 470 higher than 240 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI